SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133990
Filing Date
2022-04-29
Accepted
2022-04-29 16:35:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d280647ddefa14a.htm DEFA14A 11306
2 GRAPHIC g280647g05a40.jpg GRAPHIC 307946
3 GRAPHIC g280647g06a55.jpg GRAPHIC 158063
  Complete submission text file 0001193125-22-133990.txt   654041
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37783 | Film No.: 22876314
SIC: 2834 Pharmaceutical Preparations